-transparent.png){kind=logo}
Todralazine decreased the mutagenic activity of tested direct- and indirect-acting mutagens. Despite the marked differences between efficient todralazine doses (ED50) it was observed that, in the case of tested indirect mutagens as well as in some of the direct mutagens, the decrease of mutagenicity by todralazine was very strong, exceeding 80% in some cases.
Related Publications
K Gasiorowski, and
K Szyba, and
J Urban
January 1999,
Teratogenesis, carcinogenesis, and mutagenesis,
K Gasiorowski, and
K Szyba, and
J Urban
September 1999,
International journal of food sciences and nutrition,
K Gasiorowski, and
K Szyba, and
J Urban
March 2008,
Journal of medicinal food,
K Gasiorowski, and
K Szyba, and
J Urban
January 1987,
Environmental and molecular mutagenesis,
K Gasiorowski, and
K Szyba, and
J Urban
January 1992,
Environmental and molecular mutagenesis,
K Gasiorowski, and
K Szyba, and
J Urban
July 1978,
Cancer letters,
K Gasiorowski, and
K Szyba, and
J Urban
July 2014,
Food chemistry,
K Gasiorowski, and
K Szyba, and
J Urban
January 1968,
Revue francaise de psychanalyse,
K Gasiorowski, and
K Szyba, and
J Urban
March 2013,
Cytotechnology,
K Gasiorowski, and
K Szyba, and
J Urban
March 1979,
Mutation research,
